the Clinicaltrail of the Effection Which of Phrenic Block Using in Non-intubated Video-assisted Thoracoscopic Surgery

August 28, 2018 updated by: Shenzhen People's Hospital

Department of Anesthesiology in Shenzhen People's Hospital

Putting 80 patients divided into group S(non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia and Vagus block) and group D(non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia、Vagus block and Phrenic block)randomly,compare the volume of anesthetic and the number of increasing anesthetic during operation were compared between the two groups.If the date of group S greater than group D,it shows that the effect of anesthetic effect of group D is better than group S.

Study Overview

Detailed Description

  1. Put 80 patients divided into group S(non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia and Vagus block) and group D(non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia、Vagus block and Phrenic block)randomly.
  2. Compare the volume of anesthetic drugs between the two groups.
  3. If the date of group S greater than group D,it shows that the effect of anesthetic effect of group D is better than group S.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Shenzhen, Guangdong, China, 518020
        • Shenzhen People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient agreed to perform non-intubated video-assisted thoracoscopic surgery, and informed the possibility of intraoperative tracheal intubation or thoracotomy.
  • No conventional anesthesia contraindication, no history of thoracic surgery, good cardiopulmonary function.
  • There is no severe adhesion and calcification in the thoracic cavity, and no artificial pneumothorax is affected.
  • the patient has no serious anxiety or depression.
  • Small surgical trauma, simple steps, short time.

Exclusion Criteria:

  • Mallampati≥3.
  • BMI≥26 kg/m2.
  • Hemodynamic instability.
  • INR≥1.5.
  • Respiratory infection, persistent cough or airway mucus hypersecretion, high risk of reflux.
  • nervous system disease,such as seizure or brain edema.
  • Extensive pleural adhesions or once chest surgery.
  • PaO2<60mmHg or PaCO2>50 mmHg.
  • Central hypopnea syndrome.
  • Lung isolation should be used to protect the healthy side of the lung.
  • Complicated operation, large trauma, long time, lack of experience or poor cooperation in the surgical team.
  • Contraindications to local anesthetic.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: phrenic block group
non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia、Vagus block and Phrenic block
phrenic block by 1% ropivacaine 5ml
Active Comparator: Control group
non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia and Vagus block
no phrenic block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the volume of anesthetic drugs
Time Frame: the time of operation, an average of 4 hours
the volume of anesthetic drugs including sevoflurane,propofol and opioids during the operation
the time of operation, an average of 4 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the time to get out of bed after surgery
Time Frame: two days after surgery
note the time to get out of bed after surgery
two days after surgery
the cost of hospitalization
Time Frame: the time of hospitalization, an average of 7 days
note the the cost of hospitalization
the time of hospitalization, an average of 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Dai Z Liang, Doctor, Shenzhen People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2018

Primary Completion (Anticipated)

December 31, 2018

Study Completion (Anticipated)

December 31, 2018

Study Registration Dates

First Submitted

July 16, 2018

First Submitted That Met QC Criteria

August 28, 2018

First Posted (Actual)

August 31, 2018

Study Record Updates

Last Update Posted (Actual)

August 31, 2018

Last Update Submitted That Met QC Criteria

August 28, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe